Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Masitinib in t(4;14) Relapsed/Refractory Multiple Myeloma
NCT00866138Phase 2Completed
- Sponsor
- AB Science
- Start
- Feb 2005
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of masitinib in multiple myeloma (MM), sponsored by AB Science. Started Feb 2005; status: completed.
02
Drugs
masitinib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00866138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00866138.